Skip to main content
TipRanks
Go Ultimate75% OFF

René Kamminga Insider Profile

4 Followers

René Kamminga, Divisional Chief Executive Officer at OptiBiotix Health, holds 55.84K shares in OptiBiotix Health (Ticker: GB:OPTI). Most recently, René Kamminga Bought 12,656 shares of OptiBiotix Health on Mar 25, 2022 for an estimated value of 5.01K .

René Kamminga's Trading History

OPTI
OptiBiotix Health
Mar 25, 2022Divisional Chief Executive OfficerInformative Buy5.01K£2.46K
GB:OPTI
Insider Shares: 55.84K (6.34%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 25, 2022Informative Buy£5.01K12,656£40.00-70.70%―
Sep 01, 2021Informative Buy£4.54K8,188£55.00-65.50%―
Apr 21, 2021Informative Buy£18.34K35,000£52.00-35.20%―

You May Also Like

René Kamminga insider profile FAQ

What is the percentage of profitable transactions made by René Kamminga?
The percentage of profitable transactions made by René Kamminga is 0%.
What is the average return per transaction made by René Kamminga?
The average return per transaction made by René Kamminga is -57.10%.
What stocks does René Kamminga hold?
René Kamminga holds: GB:OPTI stocks.
What was René Kamminga’s latest transaction?
René Kamminga’s latest transaction was an Informative Buy of 5.01K .
What was René Kamminga's most profitable transaction?
René Kamminga’s most profitable transaction was an Informative Buy of GB:OPTI stock on April 21, 2021. The return on the trade was -35.20%.
What is René Kamminga's role in OptiBiotix Health?
René Kamminga's role in OptiBiotix Health is Divisional Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.